Oncomine Clinical Research Grant Program

Details for the next rounds of calls will be announced beginning of 2025 !


If you are interested in submitting a proposal for these calls, it will be mandatory to contact the Grant Management of H.U.B ( Grants.DCR.HUB@hubruxelles.be ) 1 month before the official deadline. Since only one applicant per institution is permitted, an internal evaluation committee will determine the most promising proposal to be submitted.

--For more information and if you have additional questions, please contact David Bergemann 

Applications are made via the submission portal using standard application forms made available : https://www.oncomine.com/grants

Proposal form
Grant applications should be submitted electronically in English language according to the following guidelines:
Proposals should be submitted using the specific “Clinical study proposal form” available at Oncomine.com. The form should not exceed 10 pages, single-spaced, font size 12.
Proposals should outline the planned activities to be performed for a one-year period. If your project exceeds a one-year period, please enclose information about how you intend to fund the remaining timeframe.
Research project grant application should include the following:
1.   PI identification and affiliation (including a CV)
2.   Title (short and descriptive of the work)
3.   Study type (retrospective or prospective)
4.   Background (max. 2 pages)
5.   Objectives and scope (max. 1 page)
6.   Research plan and methods, including sample cohort when applicable (max. 2 pages)
7.   Timeline with milestones and deliverables (max. 1 page)
8.   Team members and affiliation
9.   Budget, including budget justifications and requested materials/resources (max. 1 page)
10. References (max. 10 references)

To get access to this funding opportunity, your project needs to integrate an ONCOMINE NGS apporach : 
https://www.oncomine.com/assays

Applicant warrants that they have the authority to submit Applications and obtained any necessary permission to carry out the research. There is a limit of one application per institution for each current grant term. Affiliates, subsidiaries, distributors and other sales intermediaries, advertising, promotion, and fulfillment agencies of Sponsor, are not eligible to participate. Determination of eligibility is at Sponsor’s sole discretion.

Government Officials may not participate in this promotion. “Government Official” shall mean: (i) Any officer or employee of a government or any department, agency or instrument of a government; (ii) Any person acting in an official capacity for or on behalf of a government or any department, agency, or instrument of a government; (iii) Any officer or employee of a company or business, university or institution owned in whole or part by a government; (iv) Any officer or employee of a public international organization such as the World Bank or United Nations, the European Union or the World Health Organization; (v) Any officer or employee of a political party or any person acting in an official capacity on behalf of a political party; and/or (vi) Any candidate for political office. Void where prohibited, licensed, or restricted by federal, state, provincial, or local laws, regulations, or agency/institutional policy.

CRITERIA FOR SELECTION AS A GRANT RECIPIENT:
Applications will be evaluated based on scientific merit and strategic alignment with the Sponsor’s areas of scientific research. Submitted Applications will be judged by a panel of at least two external judges comprising independent and internationally recognized experts and Thermo Fisher Scientific medical scientific leadership.
Scoring of the project proposals for ranking and selection is based on the Merit of the Project (MP), to be calculated according to the following formula:
MP = 0.30 A + 0.45 B + 0.25 C
The three evaluation criteria are:
A. Scientific merit of the research team
B. Scientific merit and innovative nature of the project;
C. Nature of the requested resources;